Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/28/2018 |
Start Date: | February 6, 2017 |
End Date: | February 6, 2020 |
Contact: | Amiee Maxwell |
Email: | amiee.maxwell@hci.utah.edu |
Phone: | 801-587-4720 |
Assessment of Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas and Tumor Region-Specific Biomarker Correlation
This study evaluates the use of specialized magnetic resonance imaging (MRI) techniques
including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the
surgical treatment of gliomas. Participants will undergo an MR perfusion scan or 2-HG
spectroscopy prior to surgery and intra-operatively.
including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the
surgical treatment of gliomas. Participants will undergo an MR perfusion scan or 2-HG
spectroscopy prior to surgery and intra-operatively.
Inclusion Criteria:
- Age ≥ 18 years
- Suspected glioma (grade II, III, or IV)
- Preoperative MR perfusion (enhancing tumors)
- Preoperative MR 2-HG spectroscopy (nonenhancing tumors)Patient indicated for surgical
resection, standard radiation, and standard chemotherapy as a standard of care
- Karnofsky performance status ≥ 60
- Life expectancy > 12 weeks
- Ability to comply with study and follow-up procedures
Exclusion Criteria:
- Prior diagnosis of intracranial glioma
- Other malignancy with expected need for systemic therapy within 3 years
- Inability to have 6000 grays of radiation to the brain
- Need for urgent palliative intervention for primary disease (e.g., impending
herniation)
- Evidence of bleeding diathesis or coagulopathy
- History of intracerebral abscess within 6 months prior to Day 0
- Major surgical procedure, open biopsy, or significant traumatic injury within 28 days
prior to Day 0, anticipation of need for major surgical procedure during the course of
the study
- Pregnant or nursing females
- Subjects unable to undergo an MRI with contrast
We found this trial at
1
site
Salt Lake City, Utah 84112
Principal Investigator: Michael Karsy, MD
Phone: 801-587-4720
Click here to add this to my saved trials